Gropello Cairoli, Italy

Enrico Selva

USPTO Granted Patents = 27 

 


Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 138(Granted Patents)


Location History:

  • Gropello Cairoli (PV), IT (1984)
  • Via Di Vittorio, IT (1993 - 1998)
  • Gropello Cairoli, IT (1986 - 2011)

Company Filing History:


Years Active: 1984-2011

Loading Chart...
Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: **Innovations of Enrico Selva: A Pioneer in Antibiotics and Medicinal Chemistry**

Introduction

Enrico Selva, an accomplished inventor from Gropello Cairoli, Italy, has made significant contributions to the fields of antibiotics and medicinal chemistry. With an impressive portfolio of 27 patents, Selva showcases his dedication to advancing science and healthcare through innovative solutions. His work primarily revolves around the development of antibiotic compounds and novel medicinal derivatives, making a substantial impact on the pharmaceutical industry.

Latest Patents

Two of Selva's latest patents reflect his innovative spirit and scientific expertise. The first patent, titled "Antibiotics GE 81112 factors A, B, B1, pharmaceutically acceptable salts and compositions, and use thereof," pertains to antibiotic substances derived from microbial origins. These compounds, produced through the fermentation of strain DSMZ 14386, exhibit antibacterial activity against susceptible microbes, positioning them as valuable agents in combating infections.

The second patent focuses on "Hydroxylamine derivatives," which involves the synthesis of hydroxylamino derivatives defined by a specific general formula. These compounds are crucial for their potential use in treating central nervous system degenerative disorders associated with protein misfolding and misaggregation. The patent details innovative methods for preparing these derivatives, alongside their pharmaceutical compositions.

Career Highlights

Throughout his career, Enrico Selva has been associated with notable companies such as Gruppo Lepetit S.p.a. and Vicuron Pharmaceuticals Inc. His roles in these organizations have allowed him to contribute to groundbreaking research and the development of cutting-edge pharmaceutical products. The intersection of his research capabilities and industry experience has solidified Selva's reputation as a thought leader in his field.

Collaborations

Enrico Selva has worked closely with several esteemed colleagues, including Maurizio Denaro and Giovanni Cassani. These collaborations have fostered a productive exchange of ideas and expertise, further enhancing the quality and scope of Selva's research initiatives. Together, they have aimed to tackle pressing health challenges through innovative approaches to drug development.

Conclusion

Enrico Selva stands out as a remarkable inventor whose contributions to antibiotics and medicinal chemistry deliver substantial benefits to public health. With a robust portfolio of patents that reflect his innovative mindset and industrial collaboration, Selva continues to inspire the next generation of inventors and researchers. His work serves as a testament to the power of innovation in transforming healthcare and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…